What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - A phase 2, multicenter, open-label study to assess appropriate dosing and to evaluate safety ofcrizanlizumab, with or without hydroxyurea/hydroxycarbamide, in sequential,descending age groups of pediatric sickle cell disease patients with vaso-occlusive crisis. Contact Protocol code: CSEG101B2201 EudraCT code: 2017-001747-12 Pathology: Células Falciformes con crisis vaso-oclusivas. Pharmac: Crizanlizumab, with or without Hydroxyurea/Hydroxycarbamide Promoter: Novartis Principal investigator: Díaz de Heredia Rubio, Maria Cristina Research group: Càncer i malalties hematològiques infantils Service: Oncohematologia Pediàtrica Phase: Fase II Recruiting: Closed Status: Cerrado Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio multicéntrico, aleatorizado, con doble enmascaramiento y controlado con placebo de la eficacia y la seguridad de LJPC-501 en pacientes pediátricos de >2 a 17 años de edad con hipotensión resistente a las catecolaminas asociada a shockdistributivo. Contact Protocol code: LJ501-CRH04 EudraCT code: 2017-005153-37 Pathology: Hipotensión resistente a las catecolaminas asociada a shock distributivo Pharmac: LJPC-501 Promoter: La Jolla Pharmaceutical Principal investigator: Balcells Ramirez, Joan Research group: Recerca clínica/Innovació en la pneumònia i sèpsia Service: UCI Pediatria Phase: Phase II Recruiting: Closed Status: Cerrado Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo internacional pediátrico en tumor hepático Contact Protocol code: RG_15-114 EudraCT code: 2016-002828-85 Pathology: Hepatoblastoma y carcinoma hepatocelular Pharmac: C5VD, SIOPEL-3 high risk, cisplatin monotherapy, GEMOX Promoter: University of Birmingham Principal investigator: Sábado Álvarez, Constantino Research group: Childhood Cancer and Blood Disorders Service: Pediatric Oncohematology Phase: Fase III Recruiting: Closed Status: Finalizado Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Segundo estudio internacional intergrupo para el linfoma de Hodgkin clásico en niños y adolescentes. Estudio EuroNet-PHL-C2. Contact Protocol code: EURONET-PHL-C2 EudraCT code: 2012-004053-88 Pathology: Linfoma de Hodgkin Pharmac: DECOPDAC-21 protocol +/- radiation Promoter: Justus Liebig University of Giessen Principal investigator: Sábado Álvarez, Constantino Research group: Childhood Cancer and Blood Disorders Service: Pediatric Oncohematology Phase: Phase III Recruiting: Closed Status: Cerrado Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio prospectivo internacional de meduloblastoma riesgo estándar clínico en niños mayores de 3 a 5 años, con perfil bajo de riesgo biológico (PNET 5 MB - LR) o perfil medio de riesgo biológico (PNET 5 - SR MB).Estudio SIOP Contact Protocol code: SIOP-PNET5MB EudraCT code: 2011-004868-30 Pathology: Medulloblastoma Pharmac: neuraxis irradiation + chemotherapy Promoter: Sociedad Española de Hematología y Oncología Pediátricas Principal investigator: Llort Sales, Anna Research group: Childhood Cancer and Blood Disorders Service: Pediatric Oncohematology Phase: Phase III Recruiting: Open Status: Activo Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado de fase IIb con bevacizumab asociado a temozolomida ± irinotecán en niños y jóvenes con neuroblastoma resistente o recidivan. Contact Protocol code: RG_11-087 EudraCT code: 2012-000072-42 Pathology: Neuroblastoma Pharmac: bevacizumab added to temozolomide ± irinotecan Promoter: The University of Birmingham Principal investigator: Moreno Martín-Retortillo, Lucas Research group: Childhood Cancer and Blood Disorders Service: Pediatric Oncohematology Phase: Phase II Recruiting: Closed Status: Finalizado Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2026 Títol Complet Acuerdo Marco para la homologación de un total de 4 empresas, especializadas en consultoría regulatoria en ciencias de la vida, destinadas a ofrecer servicios a los proyectos de R+D+i de la Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR). Expedient ACUERDO MARCO CONSULTORAS ESPECIALIZADAS EN REGULA Codi 24988877 Data publicació Thu, 12 Feb 2026 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1.1 PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN Year 2026 Títol Complet Subministrament i instal·lació de sistemes de megafonia per avisos d'emergència de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient MEGAFONIA EMERGÈNCIA Codi 24988863 Data publicació Thu, 12 Feb 2026 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ PRINCIPALS PUNTS SOBRE DIGITAL ANNEX 1 PPT ANNEX 2 PPT Year 2026 Títol Complet Servicio de análisis de metilación del ADN en muestras de saliva para el Proyecto PI24/00195, destinado al Grupo de Psiquiatria, Salud Mental y Adicciones de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient ANÁLISIS METILACIÓN ADN (PI24/00195) Codi 24988864 Data publicació Thu, 12 Feb 2026 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1 PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN Year 2026 Títol Complet Servicio metodológico para la evaluación mediante método GRADE de la evidencia en diagnóstico clínico del síndrome antifosfolípido a cargo del Proyecto titulado “ISTH/EUROFORUM Taskforce to Develop Diagnostic Criteria Guidelines for Adult Antiphospholipid Syndrome”, a cargo del Grupo de Enfermedades Autoinmunes Sistémicas de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient SERVICIO PARA LA ELABORACIÓN DE CRITERIOS DIAGNÓST Codi 24988846 Data publicació Tue, 10 Feb 2026 - 12:00 Professionals Victoria Aubert Professionals Giulio Maria Fiore Professionals Guillermo Andres Larsen Professionals Jacopo Marongiu Professionals Braulio Andrés Ortega Quesada Professionals Omar Rojas Gutierrez Professionals Luis Eduardo De Sousa Soares Professionals Ana Maria Chioran Professionals Sarah Elizabeth Villarroel Bravo Medical doctor graduated Cum Laude, with experience in scientific writing, data management, and clinical care in both hospital and community settings. Currently working as research support staff at the Growth and Development Unit of VHIR (Vall d’Hebron Research Institute). Highly adaptable, with exc Professionals Mario Enrique Guerra Osorio Pagination First page « Previous page ‹ … Page 276 Page 277 Current page 278 Page 279 Page 280 … Next page › Last page »
Year 2026 Títol Complet Acuerdo Marco para la homologación de un total de 4 empresas, especializadas en consultoría regulatoria en ciencias de la vida, destinadas a ofrecer servicios a los proyectos de R+D+i de la Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR). Expedient ACUERDO MARCO CONSULTORAS ESPECIALIZADAS EN REGULA Codi 24988877 Data publicació Thu, 12 Feb 2026 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1.1 PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN
Year 2026 Títol Complet Subministrament i instal·lació de sistemes de megafonia per avisos d'emergència de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient MEGAFONIA EMERGÈNCIA Codi 24988863 Data publicació Thu, 12 Feb 2026 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ PRINCIPALS PUNTS SOBRE DIGITAL ANNEX 1 PPT ANNEX 2 PPT
Year 2026 Títol Complet Servicio de análisis de metilación del ADN en muestras de saliva para el Proyecto PI24/00195, destinado al Grupo de Psiquiatria, Salud Mental y Adicciones de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient ANÁLISIS METILACIÓN ADN (PI24/00195) Codi 24988864 Data publicació Thu, 12 Feb 2026 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1 PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN
Year 2026 Títol Complet Servicio metodológico para la evaluación mediante método GRADE de la evidencia en diagnóstico clínico del síndrome antifosfolípido a cargo del Proyecto titulado “ISTH/EUROFORUM Taskforce to Develop Diagnostic Criteria Guidelines for Adult Antiphospholipid Syndrome”, a cargo del Grupo de Enfermedades Autoinmunes Sistémicas de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient SERVICIO PARA LA ELABORACIÓN DE CRITERIOS DIAGNÓST Codi 24988846 Data publicació Tue, 10 Feb 2026 - 12:00
